75 year old woman is having a BP of 170 by 100 along with blood through her nose possibly hypertensive crisis what medication should be provider her
Reading File
search_medical_text
hypertensive crisis urgency emergency management medication treatment
search_medical_text
epistaxis nosebleed hypertension treatment elderly
GradeResponse
GradeResponse
The retrieved text covers the concept. Let me now provide a comprehensive, synthesized answer.
Hypertensive Crisis with Epistaxis — 75-Year-Old Female
First, Clarify: Urgency vs. Emergency
This is the most critical distinction before choosing a medication.
| Feature | Hypertensive Urgency | Hypertensive Emergency |
|---|---|---|
| BP | ≥180/120 mmHg | ≥180/120 mmHg |
| Target organ damage | Absent | Present (brain, heart, kidneys, eyes) |
| Symptoms | Headache, nosebleed, anxiety | Altered consciousness, chest pain, vision loss, AKI, pulmonary edema |
| Treatment setting | Can be oral, outpatient/ER | IV medications, ICU |
| BP reduction goal | Gradual over 24–48 hrs | 20–25% within 1 hour, then further over next 24 hrs |
This patient's BP of 170/100 mmHg technically does not meet the threshold for hypertensive crisis (≥180/120). It is elevated but falls in Stage 2 hypertension. However, given her epistaxis and age, urgent assessment is warranted.
Step 1 — Immediate Assessment
Before giving any medication, assess for end-organ damage:
- Neuro: Headache, confusion, visual changes → stroke/hypertensive encephalopathy
- Cardiac: Chest pain, dyspnea → ACS, acute heart failure, aortic dissection
- Renal: Oliguria, hematuria → hypertensive nephropathy
- Eyes: Fundoscopy for papilledema
Step 2 — Manage the Nosebleed
Epistaxis in hypertensive patients is often the result of chronic hypertension, not necessarily acute crisis. According to the Nosebleed (Epistaxis) clinical guideline (p. 5), hypertension has an association with epistaxis (OR 1.53), but no confirmed causal link. Treat the nosebleed directly:
- Pinch the soft part of nose for 10–15 minutes
- Lean forward, not backward
- Do not delay BP treatment while managing the bleed
Step 3 — Medication Options
A. If Hypertensive Urgency (no organ damage, BP ≥180/120 OR as in this case, urgent but stable)
Use oral agents — avoid IV. The goal is to lower BP by ~25% over 24–48 hours, not rapidly.
| Drug | Dose | Notes |
|---|---|---|
| Captopril (ACE inhibitor) | 25 mg PO, may repeat in 1–2 hrs | First-line oral option; rapid onset 15–30 min |
| Amlodipine | 5–10 mg PO | Good for elderly; long-acting CCB |
| Labetalol (oral) | 200 mg PO | Alpha+beta blocker; avoid in asthma/COPD |
| Clonidine | 0.1–0.2 mg PO | Use cautiously in elderly — rebound hypertension risk |
| Furosemide | 20–40 mg PO | If volume-overloaded (signs of edema, HF) |
⚠️ Avoid sublingual nifedipine — it causes unpredictable, precipitous BP drop and has been associated with stroke and MI, especially in elderly.
B. If Hypertensive Emergency (organ damage confirmed) — IV Agents in ICU/ED
According to Harrison's Principles of Internal Medicine, 21st Ed. (p. 7684), rapid lowering of BP below the autoregulatory threshold can precipitate cerebral ischemia or infarction in chronically hypertensive patients. The goal is a controlled, monitored reduction.
| Drug | Route | Use Case |
|---|---|---|
| Nicardipine | IV infusion | Most emergencies; safe, titratable |
| Labetalol | IV bolus/infusion | Hypertensive encephalopathy, aortic dissection |
| Hydralazine | IV bolus | Preferred in pregnancy; less ideal in elderly |
| Esmolol | IV infusion | Aortic dissection, tachycardia |
| Nitroprusside | IV infusion | Severe emergency; risk of cyanide toxicity, use cautiously in elderly |
| Nitroglycerin | IV infusion | If ACS or acute pulmonary edema co-exists |
| Clevidipine | IV infusion | Short-acting CCB; excellent BP control |
Special Considerations in a 75-Year-Old Woman
- Avoid over-aggressive lowering — elderly patients have impaired autoregulation; too-rapid BP reduction can cause falls, syncope, or stroke
- Check renal function before ACE inhibitors (captopril, enalapril)
- Assess for aortic stenosis before vasodilators
- Polypharmacy — review existing medications for interactions
- Osteoporosis risk — a BP drop causing a fall can be catastrophic
- If she is on NSAIDs (common in elderly for arthritis) — these elevate BP and blunt antihypertensives; discontinue if possible
Summary Recommendation
For a 75-year-old woman with BP 170/100 and epistaxis, with no confirmed end-organ damage:
- Manage the nosebleed with direct pressure
- Place in calm, seated position (anxiety raises BP)
- Give oral Captopril 25 mg or oral Amlodipine 5 mg
- Recheck BP in 30–60 minutes
- If BP is ≥180/120 or organ damage symptoms develop → escalate to IV therapy in ED setting
⚕️ Disclaimer: This is clinical education information. A licensed provider must evaluate the patient directly and make individualized treatment decisions.
What if we give her embro define 5mg and tell me certain 40 mg in combine
search_medical_text
amlodipine 5mg hypertension mechanism dosing side effects elderly
search_medical_text
torsemide 40mg furosemide loop diuretic hypertension dosing combination
GradeResponse
GradeResponse
Interpreting your question: "Embro" = Amlodipine 5 mg (likely a brand name variant) and "Certain 40 mg" = Torsemide 40 mg (a loop diuretic, brand name Demadex/Soaanz).
Amlodipine 5 mg + Torsemide 40 mg Combination
Individual Drug Profiles
1. Amlodipine 5 mg (Calcium Channel Blocker)
| Parameter | Detail |
|---|---|
| Class | Dihydropyridine CCB (2nd generation) |
| Mechanism | Blocks L-type calcium channels → peripheral vasodilation → reduces SVR → lowers BP |
| Onset | 6–12 hours (long-acting) |
| Duration | 24 hours (once daily) |
| BP Reduction | ~8–10 mmHg systolic |
| Starting dose | 5 mg/day in elderly ✅ |
| Max dose | 10 mg/day |
According to Harrison's (p. 7519), amlodipine is a potent vasodilator and useful in simultaneous treatment of angina and hypertension — particularly relevant if this patient has any coronary disease.
2. Torsemide 40 mg (Loop Diuretic)
| Parameter | Detail |
|---|---|
| Class | Loop diuretic |
| Mechanism | Inhibits Na⁺/K⁺/2Cl⁻ cotransporter in thick ascending loop of Henle → natriuresis + diuresis → reduces preload and plasma volume → lowers BP |
| Onset | 1 hour (oral) |
| Duration | 6–8 hours |
| Bioavailability | ~80% (superior to furosemide's ~50%) |
| BP Reduction | Reduces volume load significantly |
Per Harrison's (p. 7191), torsemide has greater oral bioavailability than furosemide, making it more predictable — beneficial in elderly patients with variable GI absorption.
40 mg torsemide ≈ 80–100 mg furosemide in potency. This is a moderate-to-high dose — must be justified clinically.
Is This Combination Appropriate for This Patient?
✅ Rationale FOR the Combination
| Reason | Explanation |
|---|---|
| Complementary mechanisms | CCB causes vasodilation; torsemide reduces volume — dual-pathway BP control |
| Resistant/uncontrolled HTN | If BP not controlled on one agent, adding a diuretic is guideline-supported |
| Volume overload signs | If patient has edema, pulmonary congestion, or HF — torsemide is appropriate |
| Bioavailability advantage | Torsemide more predictable than furosemide in elderly |
⚠️ Cautions & Monitoring in a 75-Year-Old Woman
| Risk | Detail |
|---|---|
| Hypotension / falls | Combined vasodilation + diuresis can cause orthostatic hypotension → fall risk is HIGH in elderly |
| Electrolyte depletion | Torsemide → hypokalemia, hypomagnesemia → risk of arrhythmias |
| Dehydration | 40 mg is a significant diuretic dose — monitor fluid status, especially if poor oral intake |
| Renal function | Check creatinine and eGFR; loop diuretics can worsen renal function if patient is hypovolemic |
| Amlodipine side effects | Peripheral edema (ankle swelling) — common in elderly women; torsemide may counteract this |
| Ototoxicity | High-dose loop diuretics — especially with concurrent aminoglycosides |
Monitoring Parameters
After initiating this combination:
- BP check in 1–2 hours (oral onset)
- Electrolytes (K⁺, Mg²⁺, Na⁺) within 24–48 hours
- Renal function (BUN, creatinine) in 48–72 hours
- Daily weight to assess fluid loss
- Orthostatic BP (lying → standing) — fall prevention
- Urine output monitoring
Clinical Bottom Line
For this 75-year-old woman with BP 170/100 and epistaxis:
- Amlodipine 5 mg is an excellent, well-tolerated choice ✅
- Torsemide 40 mg is appropriate only if she has signs of fluid overload, heart failure, or chronic diuretic use — it is too aggressive as routine add-on for uncomplicated hypertension at this dose
- If a diuretic is needed for BP alone, consider starting with Hydrochlorothiazide 12.5–25 mg (thiazide) rather than a high-dose loop diuretic
- If torsemide is used, potassium supplementation or a potassium-sparing agent (e.g., spironolactone) should be considered
⚕️ Disclaimer: Clinical decisions must be individualized by the treating provider based on full patient history, labs, and examination findings.
What if we give her telmisatan 40mg and Amlodipine 5mg together
search_medical_text
telmisartan 40mg ARB hypertension mechanism dosing side effects elderly
search_medical_text
telmisartan amlodipine combination therapy hypertension efficacy
GradeResponse
GradeResponse
Telmisartan 40 mg + Amlodipine 5 mg Combination
This is actually one of the most guideline-recommended combinations for hypertension management. Here's a full breakdown:
Individual Drug Profiles
1. Telmisartan 40 mg (ARB — Angiotensin Receptor Blocker)
| Parameter | Detail |
|---|---|
| Class | Angiotensin II Receptor Blocker (ARB) |
| Mechanism | Blocks AT₁ receptors → prevents angiotensin II from causing vasoconstriction and aldosterone release → lowers BP + reduces sodium retention |
| Onset | 1–2 hours |
| Half-life | ~24 hours (longest half-life among ARBs — excellent once-daily coverage) |
| BP Reduction | ~10–12 mmHg systolic |
| Starting dose | 40 mg/day ✅ |
| Max dose | 80 mg/day |
| Extra benefit | PPAR-γ agonist activity → metabolic benefits (insulin sensitivity); renal protective |
2. Amlodipine 5 mg (CCB — Calcium Channel Blocker)
| Parameter | Detail |
|---|---|
| Class | Dihydropyridine CCB (2nd generation) |
| Mechanism | Blocks L-type calcium channels → arterial vasodilation → reduces systemic vascular resistance |
| Onset | 6–12 hours |
| Half-life | 30–50 hours |
| BP Reduction | ~8–10 mmHg systolic |
| Starting dose | 5 mg/day ✅ (especially in elderly) |
| Max dose | 10 mg/day |
Why This Combination Works So Well
According to the Management of Elevated Blood Pressure and Hypertension guidelines (p. 48):
"Combining drugs from different drug classes can have additive or synergistic effects and lead to greater BP reduction than increasing the dose of one drug... combination therapy targets multiple pathophysiological pathways."
| Mechanism | Telmisartan | Amlodipine |
|---|---|---|
| RAAS blockade | ✅ Yes | ❌ No |
| Vasodilation (arterial) | ✅ Moderate | ✅ Potent |
| Sodium/water retention | ✅ Reduces | ❌ May increase slightly |
| Reflex tachycardia | ✅ Blunted | ⚠️ Can cause |
| Ankle edema (CCB side effect) | ✅ Counteracts it | ⚠️ Causes it |
The ARB directly counteracts the ankle edema caused by amlodipine — making this combination particularly well-tolerated.
Combined BP Reduction Expected
| Agent | Expected Systolic Reduction |
|---|---|
| Telmisartan 40 mg | ~10–12 mmHg |
| Amlodipine 5 mg | ~8–10 mmHg |
| Combined total | ~18–22 mmHg systolic |
For this patient with BP 170/100, combined treatment could bring BP to approximately 148–152/85–88 mmHg in the short term — approaching target range. Dose titration can further optimize this.
Is This Appropriate for This 75-Year-Old Woman?
✅ Strong Indications
| Condition | Benefit |
|---|---|
| Elderly hypertension | Both drugs are first-line for elderly patients |
| Isolated systolic HTN (common in elderly) | Amlodipine especially effective |
| Diabetic patient | Telmisartan is renoprotective + metabolic benefits |
| CKD / Proteinuria | ARB is preferred per CKD guidelines (p. 55) — reduces proteinuria |
| Coronary artery disease | Amlodipine reduces angina; telmisartan cardioprotective |
| Post-stroke prevention | Telmisartan shown to reduce stroke recurrence (PROFESS trial) |
⚠️ Cautions & Monitoring
| Risk | Detail |
|---|---|
| Hypotension | Combined vasodilation — monitor for dizziness, especially on standing (orthostatic hypotension) |
| Hyperkalemia | ARBs raise potassium — check K⁺ especially if on K⁺-sparing drugs or with CKD |
| Renal function | ARBs can transiently raise creatinine — acceptable up to 30% rise; monitor BUN/Cr |
| Avoid in pregnancy | ARBs are absolutely contraindicated in pregnancy (not applicable here) |
| Do NOT combine with ACE inhibitor | ARB + ACEI = dual RAAS blockade → increased AKI + hyperkalemia risk |
| Ankle edema | Amlodipine may still cause mild edema; telmisartan mitigates but doesn't eliminate it |
| First-dose hypotension | Especially if patient is volume-depleted or on diuretics already |
Monitoring Parameters After Starting
- BP — recheck in 1–2 weeks
- Serum potassium — within 1–2 weeks (ARB effect)
- Renal function (BUN, creatinine, eGFR) — within 2–4 weeks
- Orthostatic BP — lying and standing to assess fall risk
- Ankle edema — clinical exam at follow-up
- Electrolytes — periodic monitoring every 3–6 months
Target BP for a 75-Year-Old
| Guideline | Target |
|---|---|
| JNC / AHA 2017 | <130/80 mmHg (if tolerated) |
| ESC/ESH 2023 | <140/90 mmHg (first target); <130/80 if tolerated in elderly |
| Conservative elderly approach | <140–150 systolic to avoid hypoperfusion |
Clinical Bottom Line
Telmisartan 40 mg + Amlodipine 5 mg is an excellent, guideline-supported combination for this patient. It is:
- Complementary in mechanism (RAAS + CCB)
- Well-tolerated in elderly women
- Available as a fixed-dose combination (FDC) tablet (e.g., Twynsta®) improving adherence
- Can reduce her BP by ~18–22 mmHg, bringing her closer to target
- The ARB also protects kidneys and counteracts CCB-induced edema
If BP remains uncontrolled at these doses, the next step would be up-titration (Telmisartan 80 mg and/or Amlodipine 10 mg) or adding a thiazide diuretic (e.g., Hydrochlorothiazide 12.5 mg) as a third agent.
⚕️ Disclaimer: Treatment must be individualized by the treating provider based on full clinical evaluation, comorbidities, and lab values.
She had 10 mg Amlodipine but is complaining of headache and dizziness
search_medical_text
amlodipine 10mg side effects headache dizziness management dose reduction
search_medical_text
calcium channel blocker adverse effects elderly hypotension headache management
GradeResponse
GradeResponse
Amlodipine 10 mg — Headache & Dizziness in a 75-Year-Old
Why These Symptoms Are Happening
According to Harrison's Principles of Internal Medicine, 21st Ed. (p. 7676):
"Side effects of flushing, headache, and edema with dihydropyridine use are related to their potencies as arteriolar dilators."
At 10 mg (maximum dose), amlodipine causes maximal arterial vasodilation — this directly explains both symptoms:
| Symptom | Mechanism |
|---|---|
| Headache | Cerebral vasodilation → increased intracranial blood flow → pulsatile headache (similar to vascular/migraine-type headache) |
| Dizziness | Excessive BP reduction + peripheral vasodilation → reduced cerebral perfusion pressure → lightheadedness, especially on standing (orthostatic hypotension) |
Immediate Assessment — Do This First
Before adjusting medications, rule out dangerous causes:
| Check | Why |
|---|---|
| BP right now (lying + standing) | Is she hypotensive? Orthostatic drop? |
| Heart rate | Reflex tachycardia from vasodilation? |
| Neurological exam | Exclude stroke — new headache + dizziness in elderly with hypertension = red flag |
| Blood glucose | Rule out hypoglycemia as cause of dizziness |
| Hydration status | Dehydration amplifies amlodipine hypotension |
Management Options
Option 1 — Dose Reduction ✅ (Most Appropriate)
Reduce amlodipine from 10 mg → 5 mg
- Symptoms are dose-dependent; lower dose reduces vasodilatory side effects
- BP can be maintained by optimizing telmisartan (up-titrate to 80 mg if needed)
- Most practical and safest first step in a 75-year-old
Option 2 — Switch to a Different CCB
If symptoms persist even at 5 mg, consider switching to:
| Alternative | Advantage |
|---|---|
| Lercanidipine 10 mg | More vascular-selective, significantly less headache and edema than amlodipine |
| Felodipine 5 mg | Similar profile to amlodipine but slightly less flushing/headache |
| Diltiazem (non-DHP CCB) | Less vasodilatory headache; also slows heart rate — good if tachycardia present |
Option 3 — Add a Third Agent Instead
If BP control requires 10 mg amlodipine but symptoms are intolerable, consider:
- Reduce amlodipine to 5 mg + add Hydrochlorothiazide 12.5 mg or Indapamide 1.5 mg (thiazide diuretics)
- This maintains BP control through a different mechanism while reducing the CCB dose and its side effects
Option 4 — Symptomatic Management (Short-term only)
| Symptom | Measure |
|---|---|
| Headache | Paracetamol (acetaminophen) 500–1000 mg — avoid NSAIDs (raise BP) |
| Dizziness | Rise slowly from sitting/lying, hold rails, ensure hydration |
| Flushing/headache timing | Take amlodipine at bedtime instead of morning — peak vasodilation occurs during sleep, reducing daytime symptoms |
Summary — Recommended Action Plan
Step 1: Check BP (lying + standing) and HR right now
Step 2: Rule out stroke / serious neurological cause
Step 3: Reduce Amlodipine 10 mg → 5 mg
Step 4: Up-titrate Telmisartan 40 mg → 80 mg to compensate
Step 5: If BP still uncontrolled, add Indapamide 1.5 mg (thiazide)
Step 6: If headache/dizziness persist at 5 mg, switch to Lercanidipine
Step 7: Recheck BP and symptoms in 1–2 weeks
Key Point for Elderly Patients
In a 75-year-old woman, dizziness from amlodipine is not just a comfort issue — it is a fall and fracture risk. A hip fracture in this age group carries up to 30% mortality at 1 year. Dose reduction is not optional — it is a safety imperative.
⚕️ Disclaimer: All medication changes must be made by the treating provider based on full clinical assessment.
This is a shared conversation. Sign in to Orris to start your own chat.